info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cerebral Vasospasm Companies

Cerebral vasospasm is a condition characterized by the narrowing of blood vessels in the brain, often occurring after a subarachnoid hemorrhage (SAH), which is bleeding into the space surrounding the brain. This narrowing can lead to reduced blood flow to the brain, resulting in potentially serious complications such as ischemic stroke. Various companies are involved in the research, development, and commercialization of products and therapies aimed at addressing cerebral vasospasm.

Cerebral Vasospasm Key Companies

 

Latest Cerebral Vasospasm Companies Update


Headsense Medical Developed a novel external cooling device aiming to prevent vasospasm by lowering brain temperature. The device remains in clinical trials.


Bristol-Myers Squibb Company Continued research on nimodipine, a calcium channel blocker with limited efficacy in preventing vasospasm but still utilized in clinical practice.


Other players Smaller companies and research institutions are actively investigating new drugs and treatment modalities, but major breakthrough news is lacking at the moment.


List of Cerebral Vasospasm Key Companies in the Market



  • Headsense Medical Ltd.,

  • Braun Melsungen,

  • Minnetronix,

  • Bristol-Myers Squibb Company,

  • Ingehlium GmbH,

  • Lundbeck A/S,

  • Actellion Pharmaceuticals Ltd.,

  • GE Healthcare,

  • Edge Therapeutics Inc.,

  • Siemens AG,

  • Aritria Medical,

  • Philips N.V.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.